| Schedule of Stockholders Equity |
For the three months ended June 30, 2026:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Ordinary Shares | | Additional Paid-in Capital | | Retained Earnings (Accumulated Deficit) | | | | Accumulated Other Comprehensive Income (Loss) | | Shareholders' Equity Attributable to Adient | | Shareholders' Equity Attributable to Noncontrolling Interests | | Total Equity | | Balance at March 31, 2026 | | $ | — | | | $ | 3,586 | | | $ | (1,161) | | | | | $ | (712) | | | $ | 1,713 | | | $ | 304 | | | $ | 2,017 | | | Net income | | — | | | — | | | 25 | | | | | — | | | 25 | | | 11 | | | 36 | | | Foreign currency translation adjustments | | — | | | — | | | — | | | | | 2 | | | 2 | | | 3 | | | 5 | | | Realized and unrealized gains on derivatives | | — | | | — | | | — | | | | | 11 | | | 11 | | | — | | | 11 | | | | | | | | | | | | | | | | | | | | Dividends attributable to noncontrolling interests | | — | | | — | | | — | | | | | — | | | — | | | (34) | | | (34) | | | | | | | | | | | | | | | | | | | | Repurchases of common stock | | — | | | (30) | | | — | | | | | — | | | (30) | | | — | | | (30) | | | Share based compensation and other | | — | | | 8 | | | — | | | | | — | | | 8 | | | — | | | 8 | | | | | | | | | | | | | | | | | | | Balance at June 30, 2026 | | $ | — | | | $ | 3,564 | | | $ | (1,136) | | | | | $ | (699) | | | $ | 1,729 | | | $ | 284 | | | $ | 2,013 | |
For the nine months ended June 30, 2026:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Ordinary Shares | | Additional Paid-in Capital | | Retained Earnings (Accumulated Deficit) | | | | Accumulated Other Comprehensive Income (Loss) | | Shareholders' Equity Attributable to Adient | | Shareholders' Equity Attributable to Noncontrolling Interests | | Total Equity | | Balance at September 30, 2025 | | $ | — | | | $ | 3,602 | | | $ | (1,166) | | | | | $ | (670) | | | $ | 1,766 | | | $ | 297 | | | $ | 2,063 | | | Net income | | — | | | — | | | 30 | | | | | — | | | 30 | | | 32 | | | 62 | | | Foreign currency translation adjustments | | — | | | — | | | — | | | | | (24) | | | (24) | | | 8 | | | (16) | | | Realized and unrealized losses on derivatives | | — | | | — | | | — | | | | | (5) | | | (5) | | | — | | | (5) | | | | | | | | | | | | | | | | | | | | Dividends attributable to noncontrolling interests | | — | | | — | | | — | | | | | — | | | — | | | (53) | | | (53) | | | | | | | | | | | | | | | | | | | | Repurchases of common stock | | — | | | (55) | | | — | | | | | — | | | (55) | | | — | | | (55) | | | Share based compensation and other | | — | | | 17 | | | — | | | | | — | | | 17 | | | — | | | 17 | | | | | | | | | | | | | | | | | | | Balance at June 30, 2026 | | $ | — | | | $ | 3,564 | | | $ | (1,136) | | | | | $ | (699) | | | $ | 1,729 | | | $ | 284 | | | $ | 2,013 | |
For the three months ended June 30, 2025:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Ordinary Shares | | Additional Paid-in Capital | | Retained Earnings (Accumulated Deficit) | | | | Accumulated Other Comprehensive Income (Loss) | | Shareholders' Equity Attributable to Adient | | Shareholders' Equity Attributable to Noncontrolling Interests | | Total Equity | | Balance at March 31, 2025 | | $ | — | | | $ | 3,686 | | | $ | (1,220) | | | | | $ | (814) | | | $ | 1,652 | | | $ | 297 | | | $ | 1,949 | | | Net income | | — | | | — | | | 36 | | | | | — | | | 36 | | | 14 | | | 50 | | | Foreign currency translation adjustments | | — | | | — | | | — | | | | | 118 | | | 118 | | | 5 | | | 123 | | | Realized and unrealized gains on derivatives | | — | | | — | | | — | | | | | 22 | | | 22 | | | — | | | 22 | | | | | | | | | | | | | | | | | | | | Dividends attributable to noncontrolling interests | | — | | | — | | | — | | | | | — | | | — | | | (27) | | | (27) | | | | | | | | | | | | | | | | | | | | Repurchases of common stock | | — | | | (50) | | | — | | | | | — | | | (50) | | | — | | | (50) | | | Share based compensation and other | | — | | | 7 | | | — | | | | | — | | | 7 | | | — | | | 7 | | | | | | | | | | | | | | | | | | | Balance at June 30, 2025 | | $ | — | | | $ | 3,643 | | | $ | (1,184) | | | | | $ | (674) | | | $ | 1,785 | | | $ | 289 | | | $ | 2,074 | |
For the nine months ended June 30, 2025:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Ordinary Shares | | Additional Paid-in Capital | | Retained Earnings (Accumulated Deficit) | | | | Accumulated Other Comprehensive Income (Loss) | | Shareholders' Equity Attributable to Adient | | Shareholders' Equity Attributable to Noncontrolling Interests | | Total Equity | | Balance at September 30, 2024 | | $ | — | | | $ | 3,712 | | | $ | (885) | | | | | $ | (693) | | | $ | 2,134 | | | $ | 309 | | | $ | 2,443 | | | Net income (loss) | | — | | | — | | | (299) | | | | | — | | | (299) | | | 43 | | | (256) | | | Foreign currency translation adjustments | | — | | | — | | | — | | | | | (10) | | | (10) | | | (2) | | | (12) | | | Realized and unrealized gains on derivatives | | — | | | — | | | — | | | | | 31 | | | 31 | | | — | | | 31 | | | | | | | | | | | | | | | | | | | | Dividends attributable to noncontrolling interests | | — | | | — | | | — | | | | | — | | | — | | | (42) | | | (42) | | Purchase of noncontrolling interest (1) | | — | | | (7) | | | — | | | | | (2) | | | (9) | | | (19) | | | (28) | | | Repurchases of common stock | | — | | | (75) | | | — | | | | | — | | | (75) | | | — | | | (75) | | | Share based compensation and other | | — | | | 13 | | | — | | | | | — | | | 13 | | | — | | | 13 | | | | | | | | | | | | | | | | | | | Balance at June 30, 2025 | | $ | — | | | $ | 3,643 | | | $ | (1,184) | | | | | $ | (674) | | | $ | 1,785 | | | $ | 289 | | | $ | 2,074 | |
(1) Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information.
|
| Schedule of AOCI |
The following table presents changes in AOCI attributable to Adient:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Nine Months Ended June 30, | | (in millions) | | 2026 | | 2025 | | 2026 | | 2025 | | Foreign currency translation adjustments | | | | | | | | | | Balance at beginning of period | | $ | (713) | | | $ | (803) | | | $ | (687) | | | $ | (673) | | | Aggregate adjustment for the period, net of tax | | 2 | | | 118 | | | (24) | | | (12) | | Balance at end of period (1) | | $ | (711) | | | $ | (685) | | | $ | (711) | | | $ | (685) | | | Realized and unrealized gains (losses) on derivatives | | | | | | | | | | Balance at beginning of period | | $ | 2 | | | $ | (10) | | | $ | 18 | | | $ | (19) | | | Current period changes in fair value, net of tax | | 24 | | | 23 | | | 31 | | | 20 | | | Reclassification to income, net of tax | | (13) | | | (1) | | | (36) | | | 11 | | | Balance at end of period | | $ | 13 | | | $ | 12 | | | $ | 13 | | | $ | 12 | | | Pension and postretirement plans | | | | | | | | | | Balance at beginning of period | | $ | (1) | | | $ | (1) | | | $ | (1) | | | $ | (1) | | | | | | | | | | | | Balance at end of period | | $ | (1) | | | $ | (1) | | | $ | (1) | | | $ | (1) | | | Accumulated other comprehensive loss, end of period | | $ | (699) | | | $ | (674) | | | $ | (699) | | | $ | (674) | |
(1) Foreign currency translation adjustments as of June 30, 2026 and 2025 include gains (losses) on designated net investment hedge instruments of $1 million and $(2) million, respectively. During the next twelve months, no gains or losses are expected to be reclassified from AOCI into Adient's consolidated statements of income (loss).
|